Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery. - Trial NCT05173090

Name: Clinical Trial NCT05173090
Creator: University of Liege
Keywords: Pain, Acute, Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery, drug, clinical trial

Access comprehensive clinical trial information for NCT05173090 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Liege and is currently Not yet recruiting. The study focuses on Pain, Acute. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT05173090

Not yet recruiting

drug

Trial Details

ClinicalTrials.gov • NCT05173090

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

Study Focus

Disease/Condition

Pain, Acute

Drug/Device/Intervention

Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery

Study Type

Interventional

Intervention Type

drug

Sponsor & Location

Primary Sponsor

University of Liege

Timeline & Enrollment

Phase

N/A

Start Date

Jan 15, 2022

End Date

Jul 30, 2022

Enrollment

120 participants

Primary Outcome

Patient's pain

Summary

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

ICD-10 Classifications

Acute pain

Pain, unspecified

Pain, not elsewhere classified

Acute abdomen

Acute myringitis

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT05173090

Type

Non-Device Trial